Full-Time
Research Assistant
Accelerates antibody drug discovery with data science
Junior, Mid, Senior
Vancouver, BC, Canada
- You enjoy bench work and are looking for an opportunity to hone your technical skill set
- You are able to work in a self-directed manner and demonstrate initiative
- You can accommodate a 7 am to 3 pm schedule
- You thrive in a collaborative, fast-paced work environment
- You take pride in being a self-motivated person, fast learner and team player
- Minimum BSc, work experience in a laboratory environment preferred
- Excellent communication, documentation and organizational skills
- Impeccable attention to detail
- Proven interpersonal skills with the ability to work collaboratively
- (Optional, but desired) Experience with mammalian tissue isolation and processing, cell culture
- Supporting the high-throughput screening of single cells in collaboration with project teams to meet deliverables and timelines
- Preparation of cell isolates from primary sources
- Contributing to and executing cell enrichment protocols
- Preparing, labeling and aliquoting common lab reagents to support cell screening workflows
- Maintaining cell stocks and freezer inventories
- Collaborating with lab management teams to organize, order and maintain common inventories and reagents
- Performing lab organization and maintenance tasks
- Transporting samples between company sites (< 2 km)
- Maintaining and implementing standard operating procedures while recognizing and addressing opportunities for improvements
- Gaining expertise in routine cell screening procedures and growing your technical skill set
AbCellera stands out as a leader in the biotech industry due to its unique approach to antibody drug discovery, combining expert teams, advanced technology, and data science to expedite the process from target to clinic across various therapeutic areas. The company's competitive edge lies in its ability to enable swift progress, cost reduction, and problem-solving in drug development for both innovative biotechs and leading pharmaceutical companies. Furthermore, AbCellera's commitment to technical innovation is evident in its recent presentation of new data on two T-Cell Engager Programs at SITC 2023, demonstrating its active role in advancing the field.
Company Stage
Series A
Total Funding
$393.1M
Headquarters
Vancouver, Canada
Founded
2012